Glomerular hemoclynamics in cyclosporine nephrotoxicity following uninephrectomy. Experiments were performed to determine the cause of the reduced glomerular filtration rate (GFR) in cyclosporine nephrotoxicity during compensatory renal growth. Sprague-Dawley rats were uninephrectomized and given daily injections of cyclosporine (30 mgI kg, i.m.) or vehicle (olive oil), and studied 7 or 14 days later. In cyclosporine treated rats GFR was lower seven days (1.34 0.10 vs.
1.68 0.07 mI/mm) and 14 days (1.19 0.08 vs. 1.58 0.04, P <0.025) following uninephrectomy. Arterial blood pressure, cardiac output and renal blood flow (RBF) were not different in cyclosporine and control rats. Kidney mass increased to the same extent in cyclosporine and control rats. Micropuncture of the glomerular microcirculation in similarly prepared Munich-Wistar rats demonstrated low whole kidney GFR (1.10 0.07 vs. 1.55 0.13 mllmin, P <0.01), and single nephron GFR (31.07 2.27 vs. 42.36 2.47 nI/mm, P < 0.005) in cyclosporine treated rats as compared to controls. Single nephron plasma flow, afferent and efferent arteriolar resistance, the transglomerular hydrostatic pressure gradient, and arterial blood pressure were the same in both groups. The glomerular capillary ultrafiltration coefficient (Kr) was lower in cyclosporine treated rats compared to controls [0.039 0.002 vs. 0.075 0.013 nl/(sec . mm Hg), P < 0.0251. We conclude that in this model of cyclosporine nephrotoxicity the low GFR is caused solely by a reduction in Kf, and that cyclosporine can reduce GFR without causing renal vasoconstriction.
Immunosuppression with cyclosporine immediately following renal transplantation is frequently complicated by acute renal failure [1] [2] [3] [4] [5] . More chronic administration improves graft survival but is associated with higher levels of serum creatinine than are found in a cohort of patients treated with azathioprine [6] . The effects of allograft rejection and ischemia on kidney function, however, have obscured a clear understanding of the pathogenesis of this syndrome as it occurs in man. Experimental evidence suggests that the fall in glomerular filtration rate (GFR) in cyclosporine nephrotoxicity is due to renal vasoconstriction [7] [8] [9] [10] [11] [12] , but the fall in GFR can be disproportionate to changes in renal blood flow [(RBF), 8] and selective hypofiltralion in the absence of lowered renal perfusion has been reported [13] . The hemodynamic determinants of the reduced GFR in chronic cyclosporine nephrotoxicity need further clarification.
For these reasons we have performed experiments to determine the hemodynamic determinants of the reduced glomerular therefore studied the effects of cyclosporine when it is administered chronically to rats following uninephrectomy. The effects of cyclosporine on renal function during compensatory renal growth could then be studied in the absence of ischemia and rejection. Our studies show that cyclosporine does not interfere with the expected increase in renal mass following uninephrectomy. Cyclosporine reduces GFR when given after uninephrectomy, but the reduced GFR is not caused by renal vasoconstriction or changes in renal vascular resistance. The fall in GFR is due to a reduction in the glomerular capillary ultrafiltration coefficient (Kf).
Methods
Balance and clearance experiments were performed in a total of 74 Sprague-Dawley rats (275 to 325 g) and micropuncture in sixteen Munich-Wistar rats (200 to 275 g).
Animal preparation Daily administration of cyclosporine to rats reduces food intake, and animals so treated lose weight [7, 10, 17, 18] . For this reason our studies were performed under conditions of paired feeding so that differences in food intake would not be responsible for any observed differences in renal hemodynamics or renal growth. All animals were placed in metal metabolic cages fitted with fine-mesh screens. Each animal was offered 15 grams of a standard rat chow (Rat Chow 5012, Ralston Purina Co., St. Louis, Missouri, USA, containing 22.8% protein, 4.5% fat, 4.6% fiber and water) and 50 ml of tap water daily. After a period of four to six days, when rats ate their allotted portions of food, they underwent a right uninephrectomy. Using sterile conditions and ether anesthesia the kidney was approached via a flank incision, carefully avoiding the adrenal vessels. Following uninephrectomy and for 7 to 14 days thereafter animals received daily intramuscular injections of cyclosporine (SandimmuneR, Sandoz, Inc., East Hanover, New Jersey) 30 mg/kg body weight, or its vehicle, olive oil. The daily consumption of food and water was measured for each cyclosporine-treated animal and on the following day these quantities were pair-fed to controls. Urine was collected under oil in plastic cylinders to which thymol was added. Each day the rats were weighed and the 24-hour urine volume measured. A portion of the urine was frozen and stored at -20°C for later analysis of osmolality, sodium, and potassium concentration. In Sprague-Dawley rats glomerular filtration rate, renal blood flow and cardiac output were measured 7 or 14 days after uninephrectomy. In MunichWistar rats micropuncture was performed 7 to 10 days after uninephrectomy. Drug administration was witheld on the morning of study to minimize any acute effects of cyclosporine on renal function. Whole blood cyclosporine levels were measured in a separate group of similarly prepared cyclosporine injected Sprague-Dawley (N 5) and Munich-Wistar rats (N = 4) seven days after uninephrectomy and, as above, 24 hours following the last dose.
Clearance studies The preparation of rats for clearance, blood flow and micropuncture experiments has been described previously [19] . Springs, Ohio, USA), was maintained at 37 to 38°C. Polyethylene catheters were placed in the carotid artery, jugular vein and dome of the bladder. The catheter placed in the carotid artery was used for blood sampling and for measuring arterial pressure (AP) with a strain-gauge transducer (Ailtech, City of Industry, California, USA) connected to a recorder (Gould Inc., Cleveland, Ohio, USA). After cannulation of the jugular vein an infusion of isotonic NaC1 (125 mM)/NaHCO3 (25 mM) was begun at 1.0 mlJlOO g body weight/hr using a constant infusion pump (Sage, Orion Research, Cambridge, Massachusetts, USA). The infusion solution contained enough methoxy-3H]inulin (ICN Pharmaceutical Co., Irvine, California, USA) to deliver 10 to 15 jiCi per hour. Approximately 100 minutes after the infusions were started, 150 pA of blood was taken and the first of three 20 to 30 minute urine collections was begun. Blood samples were taken at 30 minute intervals throughout the experiment and spun immediately in a microcentrifuge to separate plasma from blood cells. The urine specimens were weighed and portions of plasma and urine pipetted into scintillation vials to determine the 3H activity. At the conclusion of the experiment the left kidney was removed and weighed.
Kidney growth was expressed as the difference in wet weight between the remnant kidney on the day of experiments and the contralateral kidney weighed at the time of uninephrectomy.
Renal blood flow and cardiac output were measured with 15 3 jim (OD) 85Sr-labeled microspheres (sp act 10 mCi/g; 3M
Company, St. Paul, Minnesota, USA) in 13 control and 12 cyclosporine treated rats 20]. In these studies additional catheters were placed in the femoral arteries to monitor blood pressure during sphere injection and to withdraw blood. At the end of the last clearance period, the carotid artery catheter was advanced into the left ventricle and the position of the catheter confirmed by the characteristics of the pressure tracing in vivo and later at autopsy. Microspheres were then injected as a bolus through the carotid catheter in sufficient numbers to deliver a minimum of 16,000 counts/mm to the kidney. Beginning immediately after the administration of the microspheres, and eontinuing for the next 60 seconds blood was withdrawn from the femoral artery at a constant rate using a withdrawal pump (model 351, Sage Instruments, Cambridge, Massachusetts, USA). After this time the abdominal cavity was opened, and the kidney removed, decapsulated, and placed in a preweighed glass vial containing concentrated HCI. After overnight digestion, the mixed digests and samples of femoral arterial blood were counted for calculation of renal blood flow.
In three control and three treated rats renal blood flow was measured concurrently with an electromagnetic flow probe (Model ElOI.S, lumen size 1.5 m, Carolina Medical Electronics, Inc., King, North Carolina, USA), and in two control and one cyclosporine animal RBF was measured by flow probe only. Because the left kidney was partially exposed for placement of the flow probe the surgical preparation used was similar to that used for micropuncture and the infusion protocol was modified to correct for fluid lost during surgery (vide infra).
Mean values for RBF and GFR within each group did not differ whether rats were studied using microspheres or flow probe methodology, and values for GFR and RBF have been combined within each group.
Micropuncture
Eight control and eight cyclosporine treated Munich-Wistar rats were studied with micropuncture techniques. The left kidney was exposed through a flank incision, carefully freed from the surrounding perirenal fat, and supported in a plastic cup. Its surface was bathed with mineral oil warmed to 38°C and illuminated with a fiber-optic illuminator fitted with an infrared filter to minimize heat. The ureter was cannulated with a PE-lO tubing and urine was collected under oil into preweighed test tubes. To restore fluid lost during surgery [21] , isoncotic donor rat plasma was infused through a second jugular catheter at a rate of 1.25% body weight over 30 minutes followed by a constant infusion of 10 jil/min and adjusted to replace urine output and to keep the hematocrit stable. The inulin concentration of the NaC1/NaHCO3 infusion was adjusted to deliver 150 jzCi of [methoxy-3H1 inulin per hour.
Superficial proximal tubules were punctured at random using 8 to 10 jim OD micropipettes. An oil block three to four tubule diameters in length was injected prior to tubule fluid collections and held in place when necessary by applying gentle suction through the collection pipet. Exactly timed (2 to 4 mm) collections of tubule fluid were obtained in at least four nephrons per animal. Blood was collected from superficial star vessels using glass pipettes 12 to 14 jim OD coated inside and out with a siliconizing solution (2% Dow Corning 1107). The hydrostatic pressure in superficial glomeruli (Gd, proximal tubules (UT) and star vessels (P,) were measured using glass micropipettes (1 to 2 jim OD) filled with 2 M NaC1 and attached to a servo-nulling pressure system (Model 5, Instrumentation for Physiology and Medicine, Inc., San Diego, California, USA). The criteria for accurate measurements of P0 in this fashion have been described by others 22, 23] and include a tracing which is synchronous to the simultaneously-recorded arterial pressure wave and unaccompanied by glomerular bleeding. In one cyclosporine treated animal and one control, surface gbmeruli were not present and P0 was measured by means of stop-flow pressure (nsF) [19] . The concentration of Na and K in plasma and urine was measured by flame photometry (Instrumentation Laboratory, Lexington, Massachusetts, USA). Osmolality was measured by vapor pressure osmometry (Wescor, Ogden, Utah). 3H activity in urine, plasma, and tubule fluid was determined in a liquid scintillation spectrometer (Packard Tri-Carb model 2425, Downers Grove, Illinois, USA). 855r activity in blood and kidney digests was determined in an Auto-Gamma scintillation spectrometer (Packard, Downers Grove, Illinois, USA). Cyclosporine levels in whole blood were measured by radioimmunoassay (Sandimmune' Radioimmunoassay Kit, Sandoz, East Hanover, New Jersey, USA).
The protein concentration in afferent arteriolar (CA) and efferent arteriolar (CE) plasma was measured from samples of systemic and star vessel blood, respectively, using the OPT method described by Viets et al [24] . Three-five nanoliter aliquots of plasma samples were transferred to microcuvettes made from 100 tl capillary tube previously filled with 5 d of 0.4 M borate buffer [(ph 9.3), mercaptoethanol (0.3%), and Brij solution (0.1%)]. Following transfer, 5 p1 of the OPT reagent (40% in 0.4 M borate buffer) was added and the capillary tubes sealed, mixed by centrifugation, and their fluorescence read on a fluorescence spectrophotometer (Model LS 5, Perkin-Elmer). Standard curves were run for each experiment using samples of plasma obtained from Munich-Wistar rats whose protein concentration was routinely standardized using the method of Lowry et al [25] .
Whole kidney GFR was determined by the ratio of the inulin activities in urine and plasma multiplied by the urine flow rates in ml/min. Renal blood flow was calculated using the formula:
total renal blood flow (RBF) = Kidney activity (counts/mm) x blood withdrawal rate (mI/mm) arterial blood activity (counts/mm) and cardiac output (CO) = counts/mm injected x blood withdrawal rate (mI/mm) arterial blood activity (counts/mm) SNGFR was calculated by the inulin activity in timed tubule fluid collections (cpm/min) divided by the plasma inulin activity (cpm/nl). The oncotic pressure of afferent (HA) and efferent arteriolar (HE) blood was calculated from the formula of Landis and Pappenheimer [26] as modified by Deen, Robertson and Brenner [27] where H = 1.629 C + 0.294 C2, and C (g/l00 ml) is the concentration of protein in rat plasma.
Single nephron filtration fraction was calculated by the formula:
Single nephron plasma flow (QA) was calculated by:
Glomerular blood flow (GBF) and efferent arteriolar blood flow (EABF) were calculated by: The glomerular capillary ultrafiltration coefficient (Kr) was calculated using a computerized iterative method similar to that developed by others [27, 28] . 4 g of body weight, a value not different than the weight loss in controls (13 6 g body weight). By day 11, though, body weight was significantly less in cyclosporine treated rats compared to controls (P C 0.01). The lower body weight was not due to differences in food intake, as cyclosporine and control animals were pair-fed, nor was it due to an increase in urine volume or electrolyte excretion in cyclosporine treated rats, Urine volume was reduced in cyclosporine treated animals on the first day after uninephrectomy, and the daily sodium excretion in cyclosporine treated rats tended to be lower than in controls throughout the study. Daily potassium excretion in cyclosporine treated animals also tended to be lower than pair-fed controls and reached statistical significance on days 5, 9, 11, and 12.
Cumulative sodium and potassium excretion, shown in Figure The results of clearance studies are summarized in Figure 3 . Compared to controls, GFR was lower in cyclosporine treated rats on day 7(1.34 .10 vs. 1.68 .07 ml/min, P < 0.025) and day 14(1.19 .08 vs. 1.58 .04, P < 0.025). The reduction in GFR on day 7 was not due to differences in systemic hemodynamics as systemic blood pressure (98 3 control vs. 105 2 mm Hg, cyclosporine) and cardiac output (269 9 control vs. 296 13 ml/min/kg body weight, cyclosporine) was the same in both groups. Similarly, blood pressure and cardiac output were not different at 14 days. In addition, the low GFR in cyclosporine treated rats was not due to differences in renal blood flow as values for renal blood flow were equal in cyclosporine treated rats and controls on day 7(11.6 0.7 vs. 10.8 0.4 ml! mm) and day 14 (10.4 0.7 vs. 9.9 0.2, respectively). After seven days of treatment kidney weight increased 137.4 18.2 mg in cyclosporine rats, a value equal in magnitude to the increase in kidney weight observed in controls (196.6 26.3 mg).
To explore the determinants of the reduced GFR in this model of cyclosporine nephrotoxicity further, we prepared Munich-Wistar rats in a similar fashion and measured glomerular hemodynamics in cyclosporine and control rats 7 to 10 days after uninephrectomy (Table 1) . Similar to the situation observed in Sprague-Dawley rats, body weight was equal at the time of uninephrectomy in both groups, and the magnitude of weight loss in cyclosporine treated rats (9 4 g) was equal to the weight loss in controls (17 2 Arterial blood pressure, plasma protein concentration and hematocrit were not different between cyclosporine and control rats ( Table 1) . Whole kidney glomerular filtration rate was reduced in all cyclosporine treated rats (1.10 .07 vs. 1.55 .13 ml!min, P < 0.01), as were values for single nephron GFR (31.07 2.27 vs. 42.36 2.47 nl/min, P < 0.005). In cyclosporine treated rats values for whole kidney GFR averaged 74 6% of mean values for GFR in controls, and similarly, mean SNGFR in cycbosporine rats averaged 74 5% of values for SNGFR in controls. Glomerular capillary hydrostatic pressure and intratubule hydrostatic pressure were also the same in both groups. The lower GFR in cyclosporine treated rats could not be ascribed to differences in renal perfusion pressure, afferent arteriolar oncotic pressure or the transglomerular hydrostatic pressure gradient. Mean values for nephron plasma flow in cyclosporine treated rats (147.4 13.5 nl!min) were not different from control values (177.0 20.0 nl!min). This is consistent with the observation in Sprague-Dawley rats where whole kidney blood flow was the same in cyclosporine and control groups. Calculated resistances at the afferent and efferent arteriole were the same in control and cyclosporine treated rats.
In seven of the eight control rats, the average efferent arteriolar oncotic pressure was significantly less than the mean value for the transgbomerular hydrostatic pressure gradient, a condition characterizing filtration pressure disequilibrium [27, 28] . This was also present in all cyclosporine treated rats, and thus, unique values for K1 could be computed in 15 of the 16 animals studied. As shown in Table 1 , K1 was significantly lower in cyclosporine treated rats compared to controls (0.039 0.002 vs. 0.075 0.013 nl/(sec . mm Hg, P <0.025)).
Discussion
Cyclosporine reduced GFR in both Sprague-Dawley and Munich-Wistar rats and reduced it to similar extent. In the latter species, both SNGFR and whole kidney GFR fell proportionally, indicating that the impaired glomerular filtration is distributed equally in nephrons throughout the renal cortex. Thus our measurements of the forces and flows in the superficial nephron glomerular circulation would seem to be representative of glomerular hemodynamics in deeper nephrons which are inaccessible to micropuncture. The low GFR induced by cyclosporine in Sprague-Dawley rats was not due to differences in arterial blood pressure or cardiac output, nor was it due to a reduction in renal blood flow, as this, too, was normal in cyclosporine treated rats. After 14 days of cyclosporine, treated rats lost more body weight than controls, a difference that could not be accounted for by differences in food intake, urine output or electrolyte excretion. Similar to these observations, other investigators have found that cyclosporine causes weight loss in animals which cannot be accounted for by differences in food intake or increased urine or gastrointestinal output [10, 11, 17, 18] . The cause of this effect is not apparent. The reduced sodium and potassium excretion and slight but statistically significant increase in serum potassium observed in cyclosporine treated rats have also been noted by others [11, 12, 29 , 301 and may involve direct or indirect effects of cyclosporine on tubule reabsorption. As arterial blood pressure, cardiac output and renal blood flow did not differ in control and cyclosporine treated rats, and there were no documented losses of fluid and electrolytes during the balance studies, it is unlikely that extracellular volume depletion could account for the low glomerular filtration rate in cyclosporine treated rats.
Micropuncture of the Munich-Wistar rats confirmed the whole animal data and showed that renal blood flow was not reduced in cyclosporine treated animals. Similarly, renal perfusion pressure, systemic oncotic pressure, and the transglomerular hydrostatic pressure gradient were not different from controls. The only abnormality in cyclosporine treated rats was a reduction in K1, and this was solely responsible for the fall in GFR.
As K1 is a function of both the permeability of the glomerular capillary membrane and its surface area available for filtration, one or both of these parameters may have been reduced by cyclosporine. An action of cyclosporine on the glomerular capillary ultrafiltration coefficient has been suggested by other investigators. Myers et al [8] studied recipients of cardiac transplants who had received cyclosporine for an average of 12 months. On the basis of fractional clearances of graded-sized dextrans these investigators determined that while renal blood flow was reduced, the fall in GFR was more likely explained by a low glomerular ultrafiltration capacity. More recently, Perico and associates [13] studied rats who received oral cyclosporine on alternate days for three months. In treated rats, the GFR was reduced but renal blood flow was not significantly different than controls. They too suggested that cyclosporine may lower K1. This was further supported by their observation that after seven weeks of cyclosporine, selective inhibition of renal thromboxane A2 synthesis increased GFR without changing renal blood flow, Finally, Barros ct al [91 have more recently shown that when administered acutely, cyclosporine lowers K1. The present study extends these observations by demonstrating an effect of cyclosporine on Kf following more chronic administration.
The cause of the reduced Kf was not explored, but several possibilities may be considered. Cyclosporine may activate the renin-angiotensin system and increase the local generation of angiotensin II, [9] a potent constrictor of mesangial cells [31] . Adrenergic tone can be increased following administration of cyclosporine [7] , and this too may reduce K1 [321. Alterations in renal eicosanoid metabolism has been described in cyclosporine nephrotoxicity [12, 13, 331 and such alterations may cause mesangial cell contraction and reduce K1 [34] . Recently, MeyerLehnert and Schrier [351 have shown that cyclosporine augments hormone sensitive increases in intracellular free calcium in mesangial cells and augments their contraction. Taken together the experimental evidence indicates that cyclosporine reduces K1 by increasing the state of contraction of mesangial cells under the influence of circulating or locally generated vasoconstrictors [36, 37] . It is important to note that in the study of Meyer-Lehnert and Schrier [351 an effect of cyclosporine on mesangial cells harvested from Sprague-Dawley rats occurred at cyclosporine concentrations of 5 to 10 jig/mI. These levels are similar to those described in this and another report of experimental cyclosporine nephrotoxicity [38] , but are nearly an order of magnitude greater than levels seen in clinical medicine. The nature of the species variability in the susceptibility to cyclosporine is not clear. Finally, an effect of cyclosporine on K1 may be the result of more chronic effects of the drug on glomerular architecture. Although renal morphology was not examined in the present study, chronic cyclosporine nephrotoxicity is characterized by patchy tubulointerstitial infiltrate, arteriolopathy and focal glomerular sclerosis [8, 39] . It is conceivable that an antecedent functional correlate of the latter is a reduction in K1.
It is interesting that renal blood flow was not reduced in cyclosporine treated rats, because most , but not all studies [131, point to a prominent role for renal vasoconstriction in cyclosporine nephrotoxicity. Urinary volume and sodium excretion were lower in cyclosporine treated rats during the course of the studies. Therefore, it is conceivable that these rats were volume expanded even though no differences in plasma protein concentration, hematocrit, arterial blood pressure and cardiac output were observed between the two groups. It could be argued, then, that because renal blood flow was not appropriately elevated for the state of hydration, cyclosporine treated rats had an abnormal renal vascular response to volume expansion. In a previous report abnormal vascular reactivity has been described in cyclosporine nephrotoxicity [11] . Also, it may be that the recent uninephrectomized state and the renal hyperemia that accompanies it [40] conditions the renal vasculature in such a way as to modify cyclosporine induced vasoconstriction.
For example, following uninephrectomy renal cortical renin content is lower than in intact, two-kidney controls [41] . Also, during renal growth the cross-sectional area of the intrarenal arterioles is increased [42] . These and other renal responses to uninephrectomy may have obscured the vasoconstriction commonly observed in experimental cyclosporine nephrotoxicity. We did not directly test whether uninephrectomized rats have a different susceptibility to cyclosporine nephrotoxicity than do two-kidney animals, or whether an effect of cyclosporine on either blood flow or K1 would be dose-related. We do demonstrate, however, that cyclosporine can reduce GFR without reducing RBF, that in our model the fall in GFR is not associated with changes in P0, and that the fall in GFR is due to a reduction in K1. As there is much experimental evidence to indicate that cyclosporine has both vascular and glomerular effects, the particular hemodynamic expression of cyclosporine nephrotoxicity may be conditioned by the antecedent state of the glomerular microcirculation.
The increase in kidney weight 7 or 14 days after uninephrectomy in cyclosporine treated rats was equal in magnitude to that in controls, indicating that while cyclosporine reduced the GFR it did not interfere with this measure of renal growth. It is possible that more sensitive morphologic and biochemical measures of compensatory renal growth [43] were affected by cyclosporine.
In summary, the present studies demonstrate that the daily administration of cyclosporine to rats following uninephrectomy causes renal insufficiency. While the GFR is reduced, the expected increase in renal mass is not affected by cyclosporine. In this model of chronic cyclosporine nephrotoxicity, the fall in GFR does not depend on a reduced renal blood flow or changes in P, but depends on a reduction in the glomerular capillary ultrafiltration coefficient. The mediators of this response remain to be determined, but cyclosporine can have direct effects on mesangial cell function.
